Search - tctmd.com

Displaying 1 - 20 of 84

Sort: Relevancy | Date

News Features

Heart Failure Care Has a Pipeline Problem: What’s the Fix?

Shelley Wood

December 20, 2022

News Daily News

Global Cardio-Oncology Viewpoints ‘Contextualize’ ESC Guidelines

L.A. McKeown

December 12, 2022

News Daily News

Cardiogenic Shock Outcomes Markedly Worse in De Novo HF Patients

Caitlin E. Cox

December 09, 2022

News Daily News

FDA: Endologix AAA Grafts Get New Labeling That Addresses Endoleak Potential

L.A. McKeown

December 06, 2022

Earlier Interventions and Later Redos? ‘Mature’ TAVI Still Has Growing Pains

Shelley Wood

November 28, 2022

News Conference News

Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices

L.A. McKeown

November 18, 2022

News Conference News AHA 2022

SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint

Todd Neale

November 09, 2022

News Conference News AHA 2022

Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI

L.A. McKeown

November 07, 2022

News Conference News VIVA 2022

TRANSCEND: Low-Dose DCB for PAD Still Looking Good at 2 Years

L.A. McKeown

November 03, 2022

News Opinion CV Team Dispatch

November 2022 News Roundup

L.A. McKeown

November 01, 2022

News Features

From Mountains to Meds: A Grassroots Effort Is Restocking Cath Labs in Ukraine

L.A. McKeown

October 18, 2022

News Opinion CV Team Dispatch

October 2022 News Roundup

L.A. McKeown

October 01, 2022

News Daily News

Risk of Radiation Low for Pregnant Operators When Precautions Taken

Michael O'Riordan

September 27, 2022

News Daily News

Most Patient-Reported Outcome Measures in CVD Fall Short

L.A. McKeown

September 23, 2022

News Conference News TCT 2022

Mix of Patient, Procedural, and Device Factors All Drove TAVI Advances

Caitlin E. Cox

September 19, 2022

News Conference News TCT 2022

Ultrasound for Femoral Access? Neutral Results vs Common Sense: UNIVERSAL

Yael L. Maxwell

September 19, 2022

Presentation TCT 2022

CDT: New Devices, Drugs, and Duration?

Presenter: Andrew Sharp

September 19, 2022

News Conference News TCT 2022

SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss

Michael O'Riordan

September 19, 2022

News Conference News TCT 2022

Amulet, Watchman 2.5 LAAO Devices Provide Comparable 3-Year Outcomes

Todd Neale

September 18, 2022

News Conference News TCT 2022

FLASH: More Data to Support Mechanical Thrombectomy in PE

L.A. McKeown

September 18, 2022

Advertisement

Heart Failure Care Has a Pipeline Problem: What’s the Fix?

Global Cardio-Oncology Viewpoints ‘Contextualize’ ESC Guidelines

Cardiogenic Shock Outcomes Markedly Worse in De Novo HF Patients

FDA: Endologix AAA Grafts Get New Labeling That Addresses Endoleak Potential

Earlier Interventions and Later Redos? ‘Mature’ TAVI Still Has Growing Pains

Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices

SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint

Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI

TRANSCEND: Low-Dose DCB for PAD Still Looking Good at 2 Years

November 2022 News Roundup

From Mountains to Meds: A Grassroots Effort Is Restocking Cath Labs in Ukraine

October 2022 News Roundup

Risk of Radiation Low for Pregnant Operators When Precautions Taken

Most Patient-Reported Outcome Measures in CVD Fall Short

Mix of Patient, Procedural, and Device Factors All Drove TAVI Advances

Ultrasound for Femoral Access? Neutral Results vs Common Sense: UNIVERSAL

CDT: New Devices, Drugs, and Duration?

SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss

Amulet, Watchman 2.5 LAAO Devices Provide Comparable 3-Year Outcomes

FLASH: More Data to Support Mechanical Thrombectomy in PE

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content